Pharmacodynamics and pharmacokinetics of single ascending doses of ONO 5334 in postmenopausal women

Trial Profile

Pharmacodynamics and pharmacokinetics of single ascending doses of ONO 5334 in postmenopausal women

Completed
Phase of Trial: Phase I

Latest Information Update: 23 Jul 2012

At a glance

  • Drugs ONO 5334 (Primary)
  • Indications Postmenopausal osteoporosis
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Sponsors Ono Pharmaceutical
  • Most Recent Events

    • 23 Jul 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top